[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

BRPI0719880A2 - Forma de dosagem sólida farmacêutica para administração oral e método para preparar a mesma. - Google Patents

Forma de dosagem sólida farmacêutica para administração oral e método para preparar a mesma.

Info

Publication number
BRPI0719880A2
BRPI0719880A2 BRPI0719880-9A2A BRPI0719880A BRPI0719880A2 BR PI0719880 A2 BRPI0719880 A2 BR PI0719880A2 BR PI0719880 A BRPI0719880 A BR PI0719880A BR PI0719880 A2 BRPI0719880 A2 BR PI0719880A2
Authority
BR
Brazil
Prior art keywords
preparing
same
dosage form
oral administration
solid dosage
Prior art date
Application number
BRPI0719880-9A2A
Other languages
English (en)
Inventor
Antonio A Albano
Wantanee Phuapradit
Navnit Hargovindas Shah
Zhongshui Yu
Lin Zhang
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BRPI0719880A2 publication Critical patent/BRPI0719880A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPI0719880-9A2A 2006-10-13 2007-10-04 Forma de dosagem sólida farmacêutica para administração oral e método para preparar a mesma. BRPI0719880A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US85185206P 2006-10-13 2006-10-13
US95440107P 2007-08-07 2007-08-07
PCT/EP2007/060542 WO2008043701A1 (en) 2006-10-13 2007-10-04 Pharmaceutical solid dosage forms comprising compounds micro-embedded in ionic water-insoluble polymers

Publications (1)

Publication Number Publication Date
BRPI0719880A2 true BRPI0719880A2 (pt) 2014-06-10

Family

ID=38857877

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0719880-9A2A BRPI0719880A2 (pt) 2006-10-13 2007-10-04 Forma de dosagem sólida farmacêutica para administração oral e método para preparar a mesma.

Country Status (16)

Country Link
US (1) US20080107725A1 (pt)
EP (1) EP2079447A1 (pt)
JP (1) JP2010505901A (pt)
KR (1) KR20090053858A (pt)
AR (1) AR063259A1 (pt)
AU (1) AU2007306402A1 (pt)
BR (1) BRPI0719880A2 (pt)
CA (1) CA2665604A1 (pt)
CL (1) CL2007002921A1 (pt)
IL (1) IL197871A0 (pt)
MX (1) MX2009003516A (pt)
NO (1) NO20091274L (pt)
PE (1) PE20081461A1 (pt)
RU (1) RU2009117711A (pt)
TW (1) TW200824709A (pt)
WO (1) WO2008043701A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2025674A1 (de) 2007-08-15 2009-02-18 sanofi-aventis Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
WO2011107494A1 (de) 2010-03-03 2011-09-09 Sanofi Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
US8933024B2 (en) 2010-06-18 2015-01-13 Sanofi Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013045413A1 (en) 2011-09-27 2013-04-04 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
MX2014009889A (es) * 2012-02-16 2014-11-13 Teva Pharma N-etil-n-fenil-1,2-dihidro-4,5-di-hidroxi-1-metil-2-oxo-3-quinoli ncarboxamida, preparacion y usos de los mismos.
JO3339B1 (ar) * 2012-09-11 2019-03-13 Shanghai Inst Pharmaceutical Ind شكل مستقر غير متبلور من الأغوميلاتين وعملية تحضيره والتركيبات الدوائية التي تحتوي عليه
EP3228307A1 (en) * 2016-04-05 2017-10-11 Sandoz Ag Solid dispersion comprising opioid antagonists
AU2017376544C1 (en) * 2016-12-15 2021-06-24 Hua Medicine (Shanghai) Ltd. Oral preparation of glucokinase activator and preparation method therefor
KR20240091095A (ko) * 2018-05-31 2024-06-21 후아 메디슨 (상하이) 엘티디. 글루코키나제 활성화제 및 α-글루코시다제 억제제를 함유하는 약제학적 병용물, 조성물 및 제제, 및 이들의 제조 방법 및 용도

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5900425A (en) * 1995-05-02 1999-05-04 Bayer Aktiengesellschaft Pharmaceutical preparations having controlled release of active compound and processes for their preparation
DE19515972A1 (de) * 1995-05-02 1996-11-07 Bayer Ag Arzneizubereitungen mit kontrollierter Freisetzung und Verfahren zu ihrer Herstellung
CA2277220A1 (en) * 1997-01-10 1998-07-16 Abbott Laboratories Tablet for the controlled release of active agents
DE19732903A1 (de) * 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
US20030059471A1 (en) * 1997-12-15 2003-03-27 Compton Bruce Jon Oral delivery formulation
US6350786B1 (en) * 1998-09-22 2002-02-26 Hoffmann-La Roche Inc. Stable complexes of poorly soluble compounds in ionic polymers
ATE400252T1 (de) * 1999-02-10 2008-07-15 Pfizer Prod Inc Pharmazeutische feste dispersionen
US20030180352A1 (en) * 1999-11-23 2003-09-25 Patel Mahesh V. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
JP3842131B2 (ja) * 2000-05-03 2006-11-08 エフ．ホフマン−ラ ロシュ アーゲー ヒダントイン含有グルコキナーゼ活性化物質
DE60116758T2 (de) * 2000-05-18 2006-11-02 Therics, Inc. Einkapselung eines toxischen kerns in einen nicht-toxischen bereich in einer oralen darreichungsform
BR0215212A (pt) * 2001-12-21 2004-12-07 Novo Nordisk As Ativador de carboxamida ou sulfonamida de glicoquinase, composto, composição farmacêutica, e, uso de um composto
DE60328671D1 (de) * 2002-03-26 2009-09-17 Banyu Pharma Co Ltd Neue aminobenzamidderivate
WO2003090717A1 (en) * 2002-04-23 2003-11-06 Nanotherapeutics, Inc Process of forming and modifying particles and compositions produced thereby
MY141521A (en) * 2002-12-12 2010-05-14 Hoffmann La Roche 5-substituted-six-membered heteroaromatic glucokinase activators
EP1670516A2 (en) * 2003-09-30 2006-06-21 Solubest Ltd Water soluble nanoparticles inclusion complexes

Also Published As

Publication number Publication date
CL2007002921A1 (es) 2008-05-30
IL197871A0 (en) 2009-12-24
AR063259A1 (es) 2009-01-14
JP2010505901A (ja) 2010-02-25
RU2009117711A (ru) 2010-11-20
AU2007306402A1 (en) 2008-04-17
TW200824709A (en) 2008-06-16
EP2079447A1 (en) 2009-07-22
PE20081461A1 (es) 2008-10-18
CA2665604A1 (en) 2008-04-17
KR20090053858A (ko) 2009-05-27
MX2009003516A (es) 2009-04-14
NO20091274L (no) 2009-05-28
US20080107725A1 (en) 2008-05-08
WO2008043701A1 (en) 2008-04-17

Similar Documents

Publication Publication Date Title
BRPI0719880A2 (pt) Forma de dosagem sólida farmacêutica para administração oral e método para preparar a mesma.
BRPI0914918A2 (pt) forma de dosagem farmacêutica, e, método para preparar uma forma de dosagem sólida.
BRPI0818680A2 (pt) composição farmacêutica, preparação farmacêutica, e método para preparar um forma de dosagem oral farmacêutica
IL206159A0 (en) Oral pharmaceutical dosage forms
BRPI0616703A2 (pt) forma de dosagem farmacêutica
DK2399580T3 (da) Farmaceutiske doseringsformer
IL185390A0 (en) A solid pharmaceutical dosage formulation
ZA200704163B (en) Oral medicament for the modified release of at least one active principle, in a multimicrocapsule form
BRPI0814666A2 (pt) composição farmacêutica para a administração oral, uso de uma formulação. processo para a preparação de uma forma de dosagem sólida, e, forma de dosagem sólida
BR112012003280A2 (pt) composição farmacêutica para administração oral, método para tratar uma doença, uso do composto, e, composto.
IL212008A0 (en) Alcohol-resistant sustained-release oral pharmaceutical form based on microgranules
BRPI0819534A2 (pt) Composição farmacêutica, método para tratar hiv ou aids e método para preparar uma composição farmacêutica, forma de dosagem e composição"
BRPI0905790A2 (pt) 'micropartícula, método para a fabricação de micropartícula e preparação farmacêutica
BRPI0812964A2 (pt) Forma de dosagem farmacêutica oral sólida
BRPI0918539A2 (pt) preparação farmacêutica sólida para administração oral
BRPI0807001A2 (pt) Formulação farmacêutica, e, método para preparação de uma formulação farmacêutica.
BR112012010641A2 (pt) forma de dosagem sólida oral farmacêutica, processo para sua preparação e comprimido, cápsula e sachê compreendendo a mesma
ZA200803152B (en) Oramucosal pharmaceutical dosage form
EP2206519A4 (en) MEDICINAL PREPARATION FOR ORAL ADMINISTRATION
BRPI0817863A2 (pt) Camada de proteção mecânica para uma forma de dosagem, forma de dosagem sólida famaceuticamente aceitável, comprimido, uso de uma camada de proteção mecânica e métodos para a preparação de camada de proteção mecãnica
IL195822A0 (en) Segmented pharmaceutical dosage forms
BRPI0919194A2 (pt) preparação sólida para administração oral
EP1948138A4 (en) SEGMENTED PHARMACEUTICAL FORMS
IL205975A (en) Pharmaceutical preparation suitable for rectal administration, disposable packaging and a method for increasing its stability
IL195618A0 (en) Drug administration methods

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A, 7A, 8A E 9A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]